Er denne nyhed helt ny?
Exercised options total USD 143.6 million
Secures manufacturing and supply of freeze-dried JYNNEOS® to the U.S. in 2026
COPENHAGEN, Denmark, May 6, 2025 - Bavarian Nordic A/S (OMX: BAVA) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has exercised additional options valued at USD 143.6 million under the existing contract to supply a freeze-dried formulation of JYNNEOS® smallpox vaccine.
Exercised options total USD 143.6 million
Secures manufacturing and supply of freeze-dried JYNNEOS® to the U.S. in 2026
COPENHAGEN, Denmark, May 6, 2025 - Bavarian Nordic A/S (OMX: BAVA) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), has exercised additional options valued at USD 143.6 million under the existing contract to supply a freeze-dried formulation of JYNNEOS® smallpox vaccine.
Nyheden ligger vel i, at der er sat tal på, det har jo i flere år været kendt, at BARDA ville have den frysetørrede når den kom.
6/5 2025 13:34 EliotSpitzer 3
126243 Jeg syntes at denne nyhet er meget vigtigt fordi den bekræftiger at USA fortsat er klar på et samarbejde og at de vil købe vaccinen. Med alt det som er skete med Trump II administrationen var der lidt tvivl om de fortsat var villig til at købe. Men den tvivl er nu elimineret.
